Clinical trial
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and…
NCT00252863 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00252863 |
|---|---|
| Title | DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults |
| Official title | A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Symbicort, used twice daily (b.i.d) and as needed (prn), Budesonide Turbuhaler 200 µg, Fluticasone Discus 250 µg, Formoterol Turbuhaler 4.5 µg, Terbutaline Turbuhaler 0.5 mg, Salbutamol pressurized metered dose inhaler (pMDI) 100 µg, Salmeterol Discus 50 µg, Budesonide/Formoterol Turbuhaler 160/4.5 µg, Fluticasone/Salmeterol Discus 250/50 µg and 4 more |
| Enrollment | 1,600 |
| Start date | Dec 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Mar 17, 2009 |
| Countries | Germany |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: